• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF

+ Add to Watchlist

1621:JP

15,550.0000 JPY 50.0000 0.32%

As of 23:30:00 ET on 09/01/2014.

Snapshot for Nomura NEXT FUNDS TOPIX-17 Pharmaceutical ETF (1621)

Open: 15,540.0000 High - Low: 15,550.0000 - 15,460.0000 Primary Exchange: Tokyo
Volume: 41 52-Week Range: 13,070.0000 - 15,730.0000 Beta vs TP17PHRM: 0.9481

ETF Chart for 1621

No chart data available.
  • 1621:JP 15,550.0000
  • 1D
  • 1M
  • 1Y
15,500.0000
Interactive 1621 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1621

NEXT FUNDS TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated in Japan. The objective of the Fund is to provide investment results that correspond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-03-25 Telephone: 81-3-3241-9511
Managers: -
Web Site: www.nomura-am.co.jp

Fundamentals for 1621

NAV (on 2014-09-01) 15,540.8000
Assets (M) (on 2014-09-01) 646.0000
Shares out (M) 0.04
Market Cap (M) 646.38
% Premium -0.26
Average 52-Week % Premium -0.1530
Fund Leveraged N

Dividends for 1621

Dividend Type Distribution
Dividend Frequency Annual
Last Dividend Net (on 2014-07-11) 1,067.0000
Dividend Yield (ttm) 6.86%

Performance for 1621

1-Month +3.89% 1-Year +24.85%
3-Month +12.81% 3-Year +22.00%
Year To Date +10.71% 5-Year +10.60%
Expense Ratio 0.32

Top Fund Holdings for 1621

Filing Date: 07/31/2014
Name Position Value % of Total
Takeda Pharmaceutical Co Ltd 43,012 203,320,000 22.100%
Astellas Pharma Inc 131,336 185,840,000 20.200%
Otsuka Holdings Co Ltd 22,885 75,440,000 8.200%
Daiichi Sankyo Co Ltd 36,136 68,080,000 7.400%
Eisai Co Ltd 14,221 62,560,000 6.800%
Ono Pharmaceutical Co Ltd 5,221 46,000,000 5.000%
Shionogi & Co Ltd 18,055 40,480,000 4.400%
Chugai Pharmaceutical Co Ltd 11,434 39,560,000 4.300%
Santen Pharmaceutical Co Ltd 4,237 25,760,000 2.800%
Taisho Pharmaceutical Holdings 2,863 21,160,000 2.300%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil